Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yoshinori Yanai
Correction To: Castration-Resistant Prostate Cancer Patients Who Had Poor Response on First Androgen Deprivation Therapy Would Obtain Certain Clinical Benefit From Early Docetaxel Administration
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
Related publications
Castration-Resistant Prostate Cancer: A Strategy to Enhance Response to Androgen Deprivation
Asian Journal of Andrology
Medicine
Urology
Salvage Therapy for Castration-Refractory Prostate Cancer Resistant to Docetaxel
Japanese Journal of Urology
Urology
Methylation of SRD5A2 Promoter Predicts a Better Outcome for Castration-Resistant Prostate Cancer Patients Undergoing Androgen Deprivation Therapy
PLoS ONE
Multidisciplinary
The Effects of Matrine in Combination With Docetaxel on Castration-Resistant (Androgen-Independent) Prostate Cancer
Cancer Management and Research
Oncology
Docetaxel Rechallenge in Patients With Castration-Resistant Prostate Cancer — A Review
European Oncology and Haematology
Oncology
Hematology
Androgen Deprivation Therapy for Prostate Cancer
Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients With Castration Resistant Prostate Cancer
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Clinical Study of Long-Term Docetaxel Based Chemotherapy Treatment for Patients With Castration-Resistant Prostate Cancer
Japanese Journal of Urology
Urology
Impact of Long-Term Androgen Deprivation Therapy on PSMA Ligand PET/CT in Patients With Castration-Sensitive Prostate Cancer
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging